Chromatin-immunoprecipitation and sequencing analysis confirmed that Olig2 directly targets the promoter and/or enhancer regions of Nfatc4, Dscr1/Rcan1 and Dyrk1a, the critical neurogenic genes that contribute to Down syndrome phenotypes and inhibit their expression. The gene discussed is RCAN1; the disease is Down syndrome.